FilingReader Intelligence
Pulike Bioengineering expects 65% profit jump in H1 2025
July 12, 2025 at 05:00 AM UTC•By FilingReader AI
Pulike Biological Engineering forecasts its first-half 2025 net profit will jump 45% to 65% year-on-year to RMB 10.7-12.2 billion.
Net profit excluding non-recurring items is expected to rise 40% to 60% to RMB 9.3-10.6 billion.
The company attributes growth to new products including pig pseudorabies vaccines and avian adenovirus vaccines, plus continued strong pet product sales.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when Pulike Biological Engineering publishes news
Free account required • Unsubscribe anytime